Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Liberate Bio Appoints Steven H. Bernstein, M.D. As Chief Medical Officer

PRIVATEJul 28, 2026•13 days ago

Position

Chief Medical Officer

Company

Liberate Bio

Steven H. Bernstein, M.D.
BostonBiotechnologyHealth CareTherapeutics

Description

Liberate Bio, a leader in cell therapy, has appointed Steven H. Bernstein, M.D., as its Chief Medical Officer effective July 13, 2026. Dr

Company Information

Company

Liberate Bio

Location

Boston, Massachusetts, United States

About

Liberate Bio, Inc. is a biotechnology company focused on developing genetic medicines that program immune cells directly inside the body. They are advancing innovative platforms for in vivo CAR-M programs towards clinical applications. The company aims to enhance patient access to cell therapies by overcoming manufacturing and delivery constraints.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Liberate Bio's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.